BCR-ABL-IN-1 T10488
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BCR-ABL-IN-1 is a BCR-ABL tyrosine kinase inhibitor (pIC50: 6.46) and may be used in the research of chronic myelogenous leukemia.
CAS nr:
188260-50-6
Purity:
98%
Molecular Weight:
459,44
SMILES:
NCCCN1C=CC2=C1C=CC=C2C3=NC(NC4=CC=CC(OC(F)(F)C(F)F)=C4)=NC=C3
Formula:
C23H21F4N5O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
Bcr-Abl,Bcr-Abl,Bcr-Abl
